1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Sleep Apnea Devices Market by Segments - Global Forecast to 2019

Sleep Apnea Devices Market by Segments - Global Forecast to 2019

  • February 2015
  • -
  • Micro Market Monitor
  • -
  • 144 pages

The global sleep apnea devices market is expected to grow at a CAGR of 16.6% during the forecast period of 2014 to 2019. North America is the largest market in the global sleep apnea devices market, with a market share of 51.8% as of 2013, followed by Europe and Asia. The largest share of the North American segment is associated with various driving forces, such as the increasing patient pool of sleep apnea in this region, increasing awareness level among patients and caregivers, and the availability of technologically advanced diagnostic and therapeutic devices. It is estimated that approximately 4% of men and 2% of women suffer from Obstructive Sleep Apnea (OSA) globally.

Also, the rising prevalence of comorbidities (such as drug-resistant hypertension, congestive heart failure, Type 2 diabetes, and stroke, among others) ensures that the global sleep apnea patient pool will grow in the coming years. However, the inadequate reimbursement coverage and patient compliance are perceived to hinder the growth of this market during the forecast period, 2014 to 2019.

In this report, the global sleep apnea devices market is broadly classified on the basis of segments, namely sleep apnea therapeutic devices and sleep apnea diagnostic devices. The sleep apnea therapeutic devices is further segmented based on types, into home sleep testing/portable monitoring, sleep labs, respiratory polygraphs, two-channel screening devices, single channel screening devices, and actigraphy systems. Similarly, the sleep apnea therapeutic devices market is segmented based on types, into Positive Airway Pressure (PAP) devices, masks, adaptive servo-ventilation, airway clearance systems, oxygen devices, and oral appliances. PAP devices segment is the highest contributor in the therapeutic devices market.

Further, the global sleep apnea devices market is segmented based on the geographies into North America, Europe, Asia, and the Rest of the World (RoW). The North American segment dominated the global sleep apnea devices market in 2013, with a share of 51.8%. The major factors contributing to its dominance are the increasing prevalence of sleep apnea, rising awareness among patients and caregivers about sleep apnea, and the rising popularity of oral appliances, among others. According to the American Academy of Sleep Medicine, the number of accredited sleep labs that test for sleep disorder has quadrupled in the past decade, indicative of the increasing awareness levels in this region about sleep apnea. Europe is the second-largest market for sleep apnea devices, mainly due to the increasing usage of therapeutic devices, growing prevalence of cardiology disorders, increasing prevalence of comorbidities, and presence of well-equipped sleep laboratories. Asia is estimated to be the fastest-growing market in the sleep apnea devices industry as it is projected to grow at a CAGR of 17.7% during the forecast period of 2014 to 2019.

The report has profiled the leading players of this market, along with the developments (New product launches, partnerships, agreements, collaborations, and joint ventures) done by the companies over the past few years and strategies adopted by them to sustain and strengthen their positions in the global sleep apnea devices market. Philips Respironics, a subsidiary of Philips Healthcare (Netherlands); ResMed (U.S.); Compumedics Limited (Australia); Carefusion Corporation (U.S.); Curative Medical, Inc. (U.S.); BMC Medical Co., Ltd. (China); Natus Medical Incorporated (U.S.); Fisher and Paykel Healthcare, Ltd. (New Zealand); DeVilbiss Healthcare (U.S.); Global Medical Holdings, LLC (U.S.); Itamar Medical, Ltd. (U.S.); and Weinmann Medical Devices GmbH & Co. KG (Germany), among others, are some of the key players engaged in this market.

Reasons to Buy the Report:
From an insight perspective, this research report has focused on various levels of analysis—industry analysis (industry trends and

Table Of Contents

Sleep Apnea Devices Market by Segments - Global Forecast to 2019
TABLE OF CONTENTS
1 INTRODUCTION .......................................................................................................................................... 12
1.1 OBJECTIVES OF THE STUDY .................................................................................................................................... 12
1.2 MARKET SEGMENTATION and COVERAGE .......................................................................................................... 12
1.3 STAKEHOLDERS ........................................................................................................................................................... 13
2 RESEARCH METHODOLOGY .................................................................................................................... 14
2.1 INTEGRATED ECOSYSTEM OF SLEEP APNEA DEVICES MARKET .............................................................. 14
2.2 ARRIVING AT THE GLOBAL SLEEP APNEA DEVICES MARKET SIZE ......................................................... 15
2.2.1 TOP-DOWN APPROACH .................................................................................................................................15
2.2.2 ASSUMPTIONS ....................................................................................................................................................16
3 EXECUTIVE SUMMARY .............................................................................................................................. 17
4 MARKET OVERVIEW ................................................................................................................................... 19
4.1 INTRODUCTION .......................................................................................................................................................... 19
4.1.1 STAGES OF SLEEP ...............................................................................................................................................19
4.1.1.1 Sleep Cycle ...........................................................................................................................................20
4.1.2 SLEEP DISORDERS ..............................................................................................................................................20
4.1.3 SLEEP APNEA .......................................................................................................................................................21
4.1.4 AN ANATOMY OF A SLEEP APNEA EPISODE ...........................................................................................21
4.1.5 CAUSES ..................................................................................................................................................................22
4.1.5.1 Central Sleep Apnea (CSA) .............................................................................................................22
4.1.5.2 Obstructive Sleep Apnea (OSA) ....................................................................................................22
4.1.6 SIGNS and SYMPTOMS ........................................................................................................................................23
4.1.6.1 Central Sleep Apnea .........................................................................................................................23
4.1.6.2 Obstructive Sleep Apnea(OSA) .....................................................................................................23
4.1.6.3 Signs and Symptoms in Children .....................................................................................................23
4.1.7 RISK FACTORS .....................................................................................................................................................24
4.1.7.1 Cent

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...

Frontier Pharma: Type 2 Diabetes Mellitus - GPCRs and Protein Kinases Dominate Pipeline, with Most Promising First-in-Class Targets Demonstrating Potential Disease-Modifying Effects

Frontier Pharma: Type 2 Diabetes Mellitus - GPCRs and Protein Kinases Dominate Pipeline, with Most Promising First-in-Class Targets Demonstrating Potential Disease-Modifying Effects

  • $ 6995
  • Industry report
  • December 2016
  • by GBI Research

Frontier Pharma: Type 2 Diabetes Mellitus - GPCRs and Protein Kinases Dominate Pipeline, with Most Promising First-in-Class Targets Demonstrating Potential Disease-Modifying Effects Summary Type 2 diabetes ...

Global Idiopathic Pulmonary Fibrosis Pipeline Analysis, 2016 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

Global Idiopathic Pulmonary Fibrosis Pipeline Analysis, 2016 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • $ 6500
  • Industry report
  • February 2017
  • by P&S Market Research

Pipeline Overview Idiopathic pulmonary fibrosis (IPF) is referred to as progressive and chronic interstitial pneumonia without known cause. Pulmonary fibrosis is a disease in which tissue profound in lungs ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.